Editorial Comment

Despite the mortality benefit of PSA screening1 and the improved specificity of detecting clinically significant disease with advanced imaging2 prostate cancer screening remains controversial because of the over diagnosis of indolent disease and the treatment related impact on sexual and urinary function. The ultimate goal of any cancer screening DA is to promote preference congruent and well informed screening decisions.3 Weiner et al measured the impact of various DAs on prostate cancer screening preferences in nearly 1,330 participants using a randomized survey.
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Tags: Adult Urology Source Type: research